Crinetics Pharmaceuticals (CRNX) Revenue (2017 - 2026)
Crinetics Pharmaceuticals' quarterly Revenue came in at $10.7 million in Q1 2026, up 2873.41% year-on-year from $361000.0 in Q1 2025, and up 74.22% quarter-over-quarter from $6.2 million in Q4 2025.
Crinetics Pharmaceuticals has reported Revenue for 10 years, with the latest figure at $10.7 million in Q1 2026.
- For the quarter ending Q1 2026, Revenue rose 2873.41% year-over-year to $10.7 million; the trailing twelve-month figure through Mar 2026 stood at $18.1 million (up 2277.5% YoY), and the FY2025 full-year result was $7.7 million, up 640.71% from the prior year.
- Revenue for Q1 2026 stood at $10.7 million, up from $6.2 million in the prior quarter.
- The five-year high for Revenue was $10.7 million in Q1 2026, with the low at $143000.0 in Q3 2025.
- Average Revenue over 5 years is $2.0 million, with a median of $674500.0 recorded in 2022.
- Year-over-year, Revenue slumped 76.11% in 2024 and soared 2873.41% in 2026.
- Tracing CRNX's Revenue over 5 years: stood at $709000.0 in 2022, then plunged by 51.2% to $346000.0 in 2023, then increased by 15.32% to $399000.0 in 2024, then jumped by 1444.11% to $6.2 million in 2025, then surged by 74.22% to $10.7 million in 2026.
- The last three Revenue figures came in at $10.7 million (Q1 2026), $6.2 million (Q4 2025), and $143000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.17 Bn |
| 10 | Crinetics Pharmaceuticals | 3.59 Bn | 3.59 Bn | 10.53 Mn | 10.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.73 Mn |
| Dec 31, 2025 | 6.16 Mn |
| Sep 30, 2025 | 143,000.00 |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 361,000.00 |
| Jun 30, 2024 | 399,000.00 |
| Mar 31, 2024 | 640,000.00 |
| Sep 30, 2023 | 346,000.00 |
| Jun 30, 2023 | 988,000.00 |
| Mar 31, 2023 | 2.68 Mn |
| Dec 31, 2022 | 709,000.00 |
| Sep 30, 2022 | 458,000.00 |
| Jun 30, 2022 | 439,000.00 |
| Mar 31, 2022 | 3.13 Mn |
| Dec 31, 2021 | 1.08 Mn |
| Dec 31, 2020 | -71,000.00 |
| Mar 31, 2020 | 71,000.00 |
| Dec 31, 2019 | 321,000.00 |
| Sep 30, 2019 | 505,000.00 |
| Mar 31, 2019 | 367,000.00 |
| Dec 31, 2018 | 781,000.00 |
| Sep 30, 2018 | 548,000.00 |
| Jun 30, 2018 | 657,000.00 |
| Mar 31, 2018 | 442,000.00 |
| Dec 31, 2017 | 528,000.00 |
| Sep 30, 2017 | 640,000.00 |
| Jun 30, 2017 | 832,000.00 |